Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with Crohn’s disease

Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome

(2012) J. Xu et al.   BLOOD

Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan

(2012) M. E. Bernardo et al.   BLOOD

Macrophages modulate the viability and growth of human mesenchymal stem cells

(2012) Donald O. Freytes et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone

(2011) Eva Cuzzoni et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Allogeneic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease

(2011) Jun Liang et al.   GUT

Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease

(2011) R. Ciccocioppo et al.   GUT

Mesenchymal stem cell–based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α

(2011) Yi Liu et al.   NATURE MEDICINE

Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study

(2010) J. Liang et al.   ANNALS OF THE RHEUMATIC DISEASES

The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation

(2010) Erica Valencic et al.   CYTOTHERAPY

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

(2010) Marjolijn Duijvestein et al.   GUT

Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis

(2009) E Gonzalez-Rey et al.   GUT

Mesenchymal Stem Cells Require a Sufficient, Ongoing Immune Response to Exert Their Immunosuppressive Function

(2009) P. Renner et al.   TRANSPLANTATION PROCEEDINGS

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

(2008) Katarina Le Blanc et al.   LANCET